How to Test Human-Specific Combination Immunotherapies In Vivo

Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.

The Progress of Precision Medicine in Immuno-Oncology

Nanotechnology-based products for cancer immunotherapy

Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells

Cancers, Free Full-Text

Organoid Models of Tumor Immunology: Trends in Immunology

Enhancing anti-tumour efficacy with immunotherapy combinations - The Lancet

Antibodies, Free Full-Text

How to Test Human-Specific Combination Immunotherapies In Vivo

Cancers, Free Full-Text

Modelling the tumor immune microenvironment for precision immunotherapy - Mackenzie - 2022 - Clinical & Translational Immunology - Wiley Online Library

Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy

Engineering patient-specific cancer immunotherapies

Two is better than one: combining bispecific antibodies for signal 1 and signal 2

Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma

Antigen-specific T cells, stimulation, enrichment and analysis, Miltenyi Biotec